ZNF772

gene
On this page

Also known as DKFZp686I1569

Summary

ZNF772 (zinc finger protein 772, HGNC:33106) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 772 (Q68DY9). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 400720 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 72 total
  • MANE Select transcript: NM_001144068

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33106
Approved symbolZNF772
Namezinc finger protein 772
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesDKFZp686I1569
Ensembl geneENSG00000197128
Ensembl biotypeprotein_coding
Entrez400720

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 7 protein_coding, 1 nonsense_mediated_decay

ENST00000343280, ENST00000356584, ENST00000425074, ENST00000427512, ENST00000450712, ENST00000600175, ENST00000601768, ENST00000610548

RefSeq mRNA: 3 — MANE Select: NM_001144068 NM_001024596, NM_001144068, NM_001330613

CCDS: CCDS33133, CCDS46210, CCDS82406

Canonical transcript exons

ENST00000356584 — 4 exons

ExonStartEnd
ENSE000022437195747727757477566
ENSE000034726275747663457476672
ENSE000035798575746958657474421
ENSE000036797925747566057475786

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 87.89.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.5300 / max 69.3169, expressed in 1579 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1829075.53001579

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
corpus callosumUBERON:000233687.89gold quality
adrenal tissueUBERON:001830382.94gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099181.32gold quality
cortical plateUBERON:000534380.87gold quality
ganglionic eminenceUBERON:000402380.63gold quality
ventricular zoneUBERON:000305380.04gold quality
skeletal muscle tissueUBERON:000113479.09gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.95gold quality
islet of LangerhansUBERON:000000678.67gold quality
calcaneal tendonUBERON:000370178.22gold quality
muscle of legUBERON:000138376.46gold quality
gastrocnemiusUBERON:000138876.44gold quality
muscle tissueUBERON:000238576.19gold quality
stromal cell of endometriumCL:000225576.02gold quality
heart left ventricleUBERON:000208474.94gold quality
cerebellumUBERON:000203774.82gold quality
cerebellar cortexUBERON:000212974.73gold quality
placentaUBERON:000198774.67gold quality
cerebellar hemisphereUBERON:000224574.64gold quality
right hemisphere of cerebellumUBERON:001489074.08gold quality
endometriumUBERON:000129573.72gold quality
adrenal glandUBERON:000236973.63gold quality
heartUBERON:000094873.57gold quality
prefrontal cortexUBERON:000045173.40gold quality
adenohypophysisUBERON:000219672.96gold quality
pituitary glandUBERON:000000772.73gold quality
left adrenal glandUBERON:000123472.49gold quality
tonsilUBERON:000237272.46gold quality
right adrenal glandUBERON:000123372.21gold quality
right lobe of thyroid glandUBERON:000111972.17gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no5.24

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA2529.1ZNF772Factors with multiple dispersed zinc fingers

JASPAR matrix evidence (PMIDs): PMID:39605320

miRNA regulators (miRDB)

152 targeting ZNF772, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-5692A100.0074.406850
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-3646100.0073.565283
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-3163100.0077.238605
HSA-MIR-432-3P100.0067.86705
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-574-5P100.0066.01989
HSA-MIR-223-3P99.9970.141140
HSA-MIR-548AW99.9972.573559
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-548P99.9872.253784
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-1213699.9872.815713
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-391099.9571.132227

Literature-anchored findings (GeneRIF, showing 1)

  • [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer]. (PMID:32385021)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriozfxENSDARG00000074453
danio_rerioENSDARG00000098424
mus_musculusZfy2ENSMUSG00000000103
mus_musculusZfy1ENSMUSG00000053211
rattus_norvegicusZfy1ENSRNOG00000053042

Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)

Protein

Protein identifiers

Zinc finger protein 772Q68DY9 (reviewed: Q68DY9)

All UniProt accessions (6): A0A087WTB1, C9J1S5, C9JFF8, Q68DY9, M0R084, M0R156

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (3)

UniProt IDNamesCanonical?
Q68DY9-11yes
Q68DY9-22
Q68DY9-33

RefSeq proteins (3): NP_001019767, NP_001137540, NP_001317542 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050589Ikaros_C2H2-ZFFamily

Pfam: PF00096, PF01352

UniProt features (17 total): zinc finger region 10, splice variant 2, sequence variant 2, chain 1, domain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q68DY9-F165.420.12

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 31 (showing top): TGCCTTA_MIR124A, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, MIR520D_5P, MIR524_5P, MIR5582_3P, MIR95_5P, MIR548AW, MIR3688_3P, MIR6873_3P, MIR510_3P, MIR6508_5P, MIR4760_3P, MIR12124

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

402 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF772VN1R1Q9GZP7952
ZNF772ZNF487B1APH4512
ZNF772OR4D9Q8NGE8503
ZNF772OR1K1Q8NGR3496
ZNF772AVPR2P30518493
ZNF772OR52W1Q6IF63488
ZNF772OR2AT4A6NND4445
ZNF772KRTAP4-5Q9BYR2434
ZNF772SLCO1B7G3V0H7417
ZNF772RDM1Q8NG50414
ZNF772GOLPH3LQ9H4A5410
ZNF772STK31Q9BXU1409
ZNF772TMEM121Q9BTD3403
ZNF772DNAJC12Q9UKB3399
ZNF772THOC5Q13769398

IntAct

9 interactions, top by confidence:

ABTypeScore
PEX5ZNF772psi-mi:“MI:0915”(physical association)0.560
ZNF772PEX5psi-mi:“MI:0915”(physical association)0.560
ZNF772MEOX2psi-mi:“MI:0915”(physical association)0.560
ECE1ZNF772psi-mi:“MI:0915”(physical association)0.370
ZNF772TRIM24psi-mi:“MI:0914”(association)0.350
ZNF772MEOX2psi-mi:“MI:0915”(physical association)0.000

BioGRID (8): ZNF772 (Two-hybrid), ZNF772 (Affinity Capture-RNA), ZNF772 (Affinity Capture-RNA), ZNF772 (Two-hybrid), ZNF772 (Affinity Capture-MS), ZNF772 (Affinity Capture-MS), ZNF772 (Affinity Capture-RNA), ZNF772 (Affinity Capture-MS)

ESM2 similar proteins: A0A087WUV0, A0JNB1, A1YF12, A1YG88, A2T759, B2RUI1, D3ZVT0, O43296, P0CG31, P10072, P17020, P17097, P51814, Q08ER8, Q13398, Q14590, Q3KQV3, Q3SY52, Q4V8A8, Q571J5, Q5CZA5, Q5RBX0, Q5RCD9, Q5RCX4, Q61116, Q61967, Q68DY9, Q6NX49, Q6PK81, Q80YP6, Q86UD4, Q8BFS8, Q8BV42, Q8IVP9, Q8IZ26, Q8NEK5, Q8TAU3, Q8TAW3, Q8TF47, Q8WTR7

Diamond homologs: A6NDX5, A6NN14, A6QLU5, A7MBI1, A8MQ14, B4DU55, B4DX44, O43296, O60765, O75290, O75346, O75437, O95780, P10072, P10078, P17014, P17030, P17032, P17097, P17098, P51523, P51814, P52736, P52738, P52742, Q05481, Q06730, Q06732, Q14586, Q14929, Q15928, Q16587, Q29RZ4, Q2KI58, Q3KNS6, Q3V080, Q3ZCX4, Q49AA0, Q4R6C2, Q4V8A8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

72 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance59
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

959 predictions. Top by Δscore:

VariantEffectΔscore
19:57475654:CCTT:Cdonor_loss0.9900
19:57475655:CTTAC:Cdonor_loss0.9900
19:57475656:TTA:Tdonor_loss0.9900
19:57475657:TACC:Tdonor_loss0.9900
19:57475658:A:ACdonor_gain0.9900
19:57475658:A:Cdonor_loss0.9900
19:57475658:A:Gdonor_loss0.9900
19:57475658:AC:Adonor_gain0.9900
19:57475659:C:CAdonor_loss0.9900
19:57475659:C:CCdonor_gain0.9900
19:57475659:CC:Cdonor_gain0.9900
19:57475783:GCCC:Gacceptor_gain0.9900
19:57475784:CCCC:Cacceptor_gain0.9900
19:57475791:C:CTacceptor_gain0.9900
19:57475791:C:Tacceptor_gain0.9900
19:57475784:CCC:Cacceptor_gain0.9800
19:57475785:CCC:Cacceptor_gain0.9800
19:57475797:C:CTacceptor_gain0.9800
19:57476630:TCACC:Tdonor_loss0.9800
19:57476633:C:CTdonor_loss0.9800
19:57476669:GAACC:Gacceptor_loss0.9800
19:57476670:AACC:Aacceptor_loss0.9800
19:57476670:AACCT:Aacceptor_loss0.9800
19:57476671:ACCT:Aacceptor_loss0.9800
19:57476672:CCT:Cacceptor_loss0.9800
19:57476673:CT:Cacceptor_loss0.9800
19:57476673:CTGTG:Cacceptor_loss0.9800
19:57476674:T:Cacceptor_loss0.9800
19:57476674:T:Gacceptor_loss0.9800
19:57475782:TGCCC:Tacceptor_gain0.9700

AlphaMissense

3033 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:57473331:G:CF471L0.999
19:57473331:G:TF471L0.999
19:57473333:A:GF471L0.999
19:57473415:A:CF443L0.999
19:57473415:A:TF443L0.999
19:57473417:A:GF443L0.999
19:57473482:A:GL421P0.998
19:57473751:A:CF331L0.998
19:57473751:A:TF331L0.998
19:57473753:A:GF331L0.998
19:57473388:A:CH452Q0.997
19:57473388:A:TH452Q0.997
19:57473416:A:GF443S0.997
19:57473712:G:CH344Q0.997
19:57473712:G:TH344Q0.997
19:57473722:T:GQ341P0.997
19:57473734:A:GL337P0.997
19:57473314:A:GL477P0.996
19:57473376:G:CH456Q0.996
19:57473376:G:TH456Q0.996
19:57473390:G:CH452D0.996
19:57473398:A:GL449P0.996
19:57473472:A:CH424Q0.996
19:57473472:A:TH424Q0.996
19:57473499:A:CF415L0.996
19:57473499:A:TF415L0.996
19:57473501:A:GF415L0.996
19:57473724:A:CH340Q0.996
19:57473724:A:TH340Q0.996
19:57473835:A:CF303L0.996

dbSNP variants (sampled 300 via entrez): RS1000274871 (19:57470535 A>G), RS1000279280 (19:57474746 G>A,T), RS1000718337 (19:57469712 T>C), RS1000750879 (19:57469967 A>G), RS1000787461 (19:57477389 G>C,T), RS1001150241 (19:57478385 T>G), RS1001503476 (19:57473051 T>C), RS1001592989 (19:57476815 C>G), RS1001958957 (19:57476987 G>A,C), RS1002323643 (19:57478015 C>T), RS1002403421 (19:57471518 C>G,T), RS1003205131 (19:57471919 G>A), RS1003411443 (19:57470235 C>A,T), RS1003493872 (19:57478189 G>C), RS1003604000 (19:57478552 A>C,G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression2
methacrylaldehydeaffects cotreatment, decreases expression, increases oxidation, increases abundance2
Acroleinincreases abundance, affects cotreatment, decreases expression, increases oxidation2
Ozonedecreases expression, increases oxidation, increases abundance, affects cotreatment2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
GSK-J4decreases expression1
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
alpha-pinenedecreases expression, increases oxidation, increases abundance, affects cotreatment1
di-n-butylphosphoric acidaffects expression1
abrineincreases expression1
Temozolomideincreases expression1
Air Pollutantsdecreases expression, increases abundance, increases oxidation, affects cotreatment1
Benzo(a)pyreneaffects methylation1
Cadmiumincreases abundance, increases expression1
Potassium Chloridedecreases expression, decreases response to substance1
Dronabinoldecreases expression, decreases response to substance1
Urethanedecreases expression1
Cadmium Chlorideincreases abundance, increases expression1
Volatile Organic Compoundsaffects cotreatment, decreases expression, increases oxidation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.